These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 28792659)

  • 81. Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease.
    Qi J; Esfahani DR; Huang T; Ozark P; Bartom E; Hashizume R; Bonner ER; An S; Horbinski CM; James CD; Saratsis AM
    Acta Neuropathol Commun; 2019 May; 7(1):75. PubMed ID: 31092287
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glioblastoma spheroids produce infiltrative gliomas in the rat brainstem.
    Zhou Z; Luther N; Singh R; Boockvar JA; Souweidane MM; Greenfield JP
    Childs Nerv Syst; 2017 Mar; 33(3):437-446. PubMed ID: 28236065
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis.
    Kaye EC; Baker JN; Broniscer A
    CNS Oncol; 2014 Nov; 3(6):421-31. PubMed ID: 25438813
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.
    Tauziède-Espariat A; Saffroy R; Pagès M; Pallud J; Legrand L; Besnard A; Lacombe J; Lot G; Borha A; Tazi S; Adle-Biassette H; Polivka M; Lechapt E; Varlet P
    Clin Neuropathol; 2018; 37(5):209-216. PubMed ID: 29809131
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Local delivery methods of therapeutic agents in the treatment of diffuse intrinsic brainstem gliomas.
    Goodwin CR; Xu R; Iyer R; Sankey EW; Liu A; Abu-Bonsrah N; Sarabia-Estrada R; Frazier JL; Sciubba DM; Jallo GI
    Clin Neurol Neurosurg; 2016 Mar; 142():120-127. PubMed ID: 26849840
    [TBL] [Abstract][Full Text] [Related]  

  • 86. TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG).
    Werbrouck C; Evangelista CCS; Lobón-Iglesias MJ; Barret E; Le Teuff G; Merlevede J; Brusini R; Kergrohen T; Mondini M; Bolle S; Varlet P; Beccaria K; Boddaert N; Puget S; Grill J; Debily MA; Castel D
    Clin Cancer Res; 2019 Nov; 25(22):6788-6800. PubMed ID: 31481512
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Long Non-Coding RNA H19 Drives the Proliferation of Diffuse Intrinsic Pontine Glioma with H3K27 Mutation.
    Roig-Carles D; Jackson H; Loveson KF; Mackay A; Mather RL; Waters E; Manzo M; Alborelli I; Golding J; Jones C; Fillmore HL; Crea F
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502082
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Detection of H3K27M mutation in cases of brain stem subependymoma.
    Yao K; Duan Z; Wang Y; Zhang M; Fan T; Wu B; Qi X
    Hum Pathol; 2019 Feb; 84():262-269. PubMed ID: 30389438
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Diffuse intrinsic pontine gliomas in children: Interest of robotic frameless assisted biopsy. A technical note.
    Coca HA; Cebula H; Benmekhbi M; Chenard MP; Entz-Werle N; Proust F
    Neurochirurgie; 2016 Dec; 62(6):327-331. PubMed ID: 28120771
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Diffuse Intrinsic Pontine Glioma in Children: Document or Treat?
    Pierre-Aurélien B; Alexandru S; Federico DR; Justyna K; Carmine M; Didier F
    World Neurosurg; 2016 Sep; 93():485.e11-4. PubMed ID: 27422681
    [TBL] [Abstract][Full Text] [Related]  

  • 91. In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma.
    Veringa SJ; Biesmans D; van Vuurden DG; Jansen MH; Wedekind LE; Horsman I; Wesseling P; Vandertop WP; Noske DP; Kaspers GJ; Hulleman E
    PLoS One; 2013; 8(4):e61512. PubMed ID: 23637844
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons.
    Hankinson TC; Campagna EJ; Foreman NK; Handler MH
    J Neurosurg Pediatr; 2011 Jul; 8(1):97-102. PubMed ID: 21721895
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Deceptive morphologic and epigenetic heterogeneity in diffuse intrinsic pontine glioma.
    Bugiani M; Veldhuijzen van Zanten SEM; Caretti V; Schellen P; Aronica E; Noske DP; Vandertop WP; Kaspers GJL; van Vuurden DG; Wesseling P; Hulleman E
    Oncotarget; 2017 Sep; 8(36):60447-60452. PubMed ID: 28947983
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.
    Mueller S; Taitt JM; Villanueva-Meyer JE; Bonner ER; Nejo T; Lulla RR; Goldman S; Banerjee A; Chi SN; Whipple NS; Crawford JR; Gauvain K; Nazemi KJ; Watchmaker PB; Almeida ND; Okada K; Salazar AM; Gilbert RD; Nazarian J; Molinaro AM; Butterfield LH; Prados MD; Okada H
    J Clin Invest; 2020 Dec; 130(12):6325-6337. PubMed ID: 32817593
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
    Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
    Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma.
    Hashizume R; Andor N; Ihara Y; Lerner R; Gan H; Chen X; Fang D; Huang X; Tom MW; Ngo V; Solomon D; Mueller S; Paris PL; Zhang Z; Petritsch C; Gupta N; Waldman TA; James CD
    Nat Med; 2014 Dec; 20(12):1394-6. PubMed ID: 25401693
    [TBL] [Abstract][Full Text] [Related]  

  • 97. High Prevalence of Developmental Venous Anomaly in Diffuse Intrinsic Pontine Gliomas: A Pediatric Control Study.
    Roux A; Boddaert N; Grill J; Castel D; Zanello M; Zah-Bi G; Chrétien F; Lefevre E; Ros VD; Zerah M; Puget S; Pallud J; Varlet P
    Neurosurgery; 2020 Apr; 86(4):517-523. PubMed ID: 31342064
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.
    Yamasaki F; Kurisu K; Kajiwara Y; Watanabe Y; Takayasu T; Akiyama Y; Saito T; Hanaya R; Sugiyama K
    Neuro Oncol; 2011 Jul; 13(7):791-801. PubMed ID: 21653595
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003.
    Kline C; Jain P; Kilburn L; Bonner ER; Gupta N; Crawford JR; Banerjee A; Packer RJ; Villanueva-Meyer J; Luks T; Zhang Y; Kambhampati M; Zhang J; Yadavilli S; Zhang B; Gaonkar KS; Rokita JL; Kraya A; Kuhn J; Liang W; Byron S; Berens M; Molinaro A; Prados M; Resnick A; Waszak SM; Nazarian J; Mueller S
    Clin Cancer Res; 2022 Sep; 28(18):3965-3978. PubMed ID: 35852795
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The efficacy of a biopsy of intrinsic brainstem lesions for decision making of the treatments.
    Ogiwara H; Morota N
    Childs Nerv Syst; 2013 May; 29(5):833-7. PubMed ID: 23377758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.